Stock AGN ALLERGAN PLC
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Allergan plc

Equities

AGN

IE00BY9D5467

Delayed Nyse
Other stock markets
 		5-day change 1st Jan Change
- USD -.--% Intraday chart for Allergan plc +1.73% +0.97%
Mar. 05 Allergan Aesthetics Announces the U.S. FDA Approval of JUVEDERM VOLUMA XC for Injection in the Temple Region to Improve Moderate to Severe Temple Hollowing in Adults over the Age of 21 CI
2023 Allergan Aesthetics Announces Positive Topline Results from Second Phase 3 Study of Onabotulinumtoxina for the Treatment of Platysma Prominence CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Allergan plc Announces Executive Changes
CI
Catherine M. Klema Not Stands for Re-Election to the Board of Allergan plc
CI
Allergan : Robert J. Hugin Appointed to Allergan Board of Directors
PR
Allergan plc Appoints Robert J. Hugin to the Board of Directors
CI
Allergan plc to Establish R&D Presence in Cambridge, Massachusetts; to Appoint Don Frail to Lead Hub
CI
Allergan plc Announces Management Appointment, Effective December 10, 2018
CI
Allergan plc Appoints Alexandra Wilkis Wilson as Senior Vice President of Consumer Strategy and Innovation
CI
Allergan plc Announces Board Changes
CI
Allergan Announces Management Changes
CI
Allergan plc Announces Board Changes
CI
Abbott Laboratories : Allergan appoints former Abbott executive to its board
RE
Allergan plc Announces Board Changes
CI
Allergan plc Elects John Davidson to Board of Directors
CI
Allergan : Matthew M. Walsh Appointed Executive Vice President and Chief Financial Officer of Allergan plc
PR
Allergan Appoints Matthew M. Walsh as Executive Vice President and Chief Financial Officer
CI
Allergan plc Announces Executive Changes
CI
Allergan plc Announces Promotion of Wayne Swanton as Executive Vice President, Global Operations
CI
Tessa Hilado to Retire as Executive Vice President and Chief Financial Officer of Allergan plc
CI
Alkahest Appoints Helen Jenkins as COO
CI
AbbVie : Big-name U.S. hedge funds shed healthcare stocks during the rally in second-quarter
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AGN Stock
  4. News Allergan plc
  5. Insiders